Cyclic 3'5'-adenosine monophosphate and central circulatory control in cats and dogs
- PMID: 20256
- DOI: 10.1111/j.1440-1681.1977.tb02671.x
Cyclic 3'5'-adenosine monophosphate and central circulatory control in cats and dogs
Abstract
1. Dibutyryl cyclic AMP (Db cAMP, 75-500 microgram/kg), injected into the lateral ventricle of the brain of the cat increased blood pressure, heart rate and splanchnic discharge rate. 2. ATP, but not AMP, induced similar changes; GMP in small doses increased blood pressure. 3. A number of drugs are known to activate adenylate cyclase-induced hypertension, tachycardia and increase splanchnic discharge rate. This was shown for TRH, tetracosactide and a new beta2-adrenoceptor stimulant, NAB 365. 4. Injection into the lateral ventricle of theophylline or Ro 7/2956, both inhibitors of phosphodiesterase, similarly increased blood pressure. 5. Histamine administered by the same route induced similar reactions; it is not known if this action was exerted by activation of H1- or H2-receptors. 6. Somatostatin, known to reduce cAMP levels, induced a small but significant decrease in blood pressure. Melanocyte stimulating hormone release inhibiting factor (MIF) and TSH were ineffective. 7. These results provide evidence for the possibility of a role for cAMP in the central regulation of blood pressure at suprabulbar levels.
Similar articles
-
Cyclic nucleotides and central cardiovascular control in the conscious cat.Eur J Pharmacol. 1980 Jul 25;65(2-3):193-200. doi: 10.1016/0014-2999(80)90392-1. Eur J Pharmacol. 1980. PMID: 6105085
-
cAMP as a second messenger in central blood pressure control.Naunyn Schmiedebergs Arch Pharmacol. 1975;290(4):419-23. doi: 10.1007/BF00499953. Naunyn Schmiedebergs Arch Pharmacol. 1975. PMID: 172805
-
Central depression of carotid baroreceptor pressor response, arterial pressure and heart rate by 5-hydroxytryptophan: influence of supracollicular areas of the brain.J Pharmacol Exp Ther. 1977 Aug;202(2):310-9. J Pharmacol Exp Ther. 1977. PMID: 301930
-
Further evidence for the involvement of cAMP in central blood pressure regulation.Naunyn Schmiedebergs Arch Pharmacol. 1977 Jan;296(2):177-81. doi: 10.1007/BF00508471. Naunyn Schmiedebergs Arch Pharmacol. 1977. PMID: 189230
-
Histamine and the heart.Can J Physiol Pharmacol. 1984 Jun;62(6):720-6. doi: 10.1139/y84-119. Can J Physiol Pharmacol. 1984. PMID: 6331617 Review.
Cited by
-
Altered cyclic AMP levels in specific cardiovascular brain centers of spontaneously hypertensive rats (SHR).Klin Wochenschr. 1980 Oct 1;58(19):1091-7. doi: 10.1007/BF01476879. Klin Wochenschr. 1980. PMID: 6256582
-
Neuropeptides: Central nervous system effects on nutrient metabolism.Diabetologia. 1981 Mar;20(Suppl 1):299-304. doi: 10.1007/BF00254496. Diabetologia. 1981. PMID: 27942815
-
Cyclic nucleotides and central cardiovascular control in the cat [proceedings].Br J Pharmacol. 1978 Nov;64(3):395P. Br J Pharmacol. 1978. PMID: 214195 Free PMC article. No abstract available.
-
Central blood pressure effects of guanylyl-imido-diphosphate and cyclic guanosine-monophosphate.Naunyn Schmiedebergs Arch Pharmacol. 1980 May;312(1):31-5. doi: 10.1007/BF00502571. Naunyn Schmiedebergs Arch Pharmacol. 1980. PMID: 6248798
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous